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Abstract: Plants belonging to the genus Salvia (Lamiaceae) 
are known to have a wide range of biological properties. 
In this work, extracts obtained from the aerial parts of 
Salvia sclareoides Brot. were evaluated to investigate 
their chemical composition, toxicity, bioactivity, and 
stability under in vitro gastrointestinal conditions. 
The composition of the supercritical fluid extract was 
determined by GC and GC-MS, while the identification of 
the infusion constituents was performed by HPLC-DAD 
and LC-MS. The in vitro cytotoxicity of both extracts (0-2 
mg/mL) was evaluated in Caco-2 cell lines by the MTT 
assay. The anti-inflammatory and anticholinesterase 
activities were determined through the inhibition of 
cyclooxygenase-1 and acetylcholinesterase enzymes, 
while β-carotene/linoleic acid bleaching test and the 
DPPH assays were used to evaluate the antioxidant 
activity. The infusion inhibited cyclooxygenase-1 (IC50 = 
271.0 µg/mL), and acetylcholinesterase (IC50 = 487.7 µg/
mL) enzymes, also demonstrated significant antioxidant 
properties, as evaluated by the DPPH (IC50 = 10.4 µg/mL) 
and β-carotene/linoleic acid (IC50 = 30.0 µg/mL) assays. 
No remarkable alterations in the composition or in the 
bioactivities of the infusion were observed after in vitro 
digestion, which supports the potential of S. sclareoides 
as a source of bioactive ingredients with neuroprotective, 
anti-inflammatory and antioxidant properties. 
Keywords: Salvia sclareoides, GC-MS, HPLC, bioactivity, 
in vitro digestion.
1 Introduction
Phytochemicals ingested daily or natural extracts used 
to develop new functional ingredients have become an 
important area of human nutritional and therapeutic 
research. Salvia species (Lamiaceae) have a long history 
of culinary and medicinal uses, so there is a remarkable 
interest concerning their chemistry and biological 
properties [1]. The industrial and economic importance of 
this genus has increased in recent years due to evidence 
that some of its secondary metabolites, mainly terpenes 
and polyphenols, have valuable pharmaceutical and 
nutraceutical properties [2]. Several clinical trials have 
been developed to investigate Salvia extracts, and 
promising results were obtained [3]. Ethnobotanical 
treatment strategies against Alzheimer´s disease (AD) and 
brain aging included the use of Salvia genus as a source of 
bioactive compounds [4-6]. We have focused our studies 
on Salvia sclareoides Brot., an Iberian endemic species, 
whose butanol extract revealed a promising inhibitory 
activity of AChE, an enzyme related to AD [7]. The 
phenolic profile, toxicity, antioxidant activity and prion 
binding properties were also studied [8]. More recently, 
NMR spectroscopy experiments were used to screen S. 
sclareoides extracts for their content in AChE ligands [9] 
and also for molecules that bind to Aβ 1-42 oligomers, 
recognized as highly toxic to AD [10].
Pursuing our studies on this plant, we report here, for 
the first time, the chemical composition of S. sclareoides 
supercritical fluid extracts as well as its cytotoxicity on 
Caco-2 cell line as a model of the intestinal epithelium. 
*Corresponding author: Alice Martins: Centro de Química e 
Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo 
Grande, 1749-016 Lisboa, Portugal, E-mail: aimartins@fc.ul.pt 
Daniela Batista, Pedro L. Falé, Maria L. Serralheiro, Maria-Eduarda 
Araújo, Catarina Dias, Isabel Branco, , Paulo J. A. Madeira, Amélia 
P. Rauter: Centro de Química e Bioquímica, Faculdade de Ciências, 
Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal  
Clara Grosso: REQUIMTE – LAQV, Instituto Superior de Engenharia 
do Instituto Politécnico do Porto, Rua Dr. António Bernardino de 
Almeida, 431, 4249-015 Porto, Portugal 
José Coelho, António Palavra: Centro de Química Estrutural, 
Departamento de Engenharia Química, Instituto Superior Técnico, 
Universidade de Lisboa, Av. Rovisco Pais, 1096 Lisboa Codex, Portugal 
© 2017 Daniela Batista et al., published by De Gruyter Open.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.Brought to you by | De Gruyter Trial Portugal 2018
Authenticated
Download Date | 6/3/19 1:01 PM
 Phytochemical and Biological Evaluation of Salvia sclareoides Extracts   83
Because the traditional use of this plant relies on the 
intake of the infusion, it was also evaluated on cell assays. 
Since no toxicity was denoted by the infusion, it was 
subjected to more detailed in vitro studies involving its 
anti-inflammatory, anticholinesterase and antioxidant 
properties. In addition, the infusion was submitted to a 
simulated in vitro digestive process, where the antioxidant 
activity was monitored by the DPPH assay, and HPLC-
DAD-MS/MS was used to analyze eventual alterations on 
chemical profile after gastric and pancreatic digestions. It 
is well known that inflammation and oxidative imbalance 
play a role in neurodegenerative impairments and so, our 
main goal is to explore multitarget and non-toxic plant 
constituents that maintain their bioactivities even after they 
are submitted to simulated gastrointestinal conditions. 
Overall, the aim of the present study is the valorization of 
S. sclareoides as a source of different chemical constituents 
that can be obtained by two complementary extraction 
methods. Non-polar compounds, present in volatile 
oils obtained by supercritical fluid extraction (SFE), and 
hydrophilic molecules, found in the aqueous extract, 
can be explored regarding their potential applications in 
pharmaceutical, agrochemical or food industries, giving an 
add-value to this natural resource.
2 Experimental Procedure  
2.1 Chemicals
All chemicals were of analytical grade. MTT (thiazolyl 
blue tetrazolium bromide) acetylcholinesterase from 
electric eel, pepsin, pancreatin, COX-1 (cyclooxygenase 
1) from sheep, and chemicals used to evaluate the anti-
inflammatory and antioxidant activities were supplied 
by Sigma-Aldrich (Barcelona, Spain).  DMEM (Dulbecco´s 
modified Eagle’s medium), HBSS (Hanks´ balanced 
salt solution) with and without phenol red, glutamine, 
Pen-Strep (penicillin and streptomycin mixture), PBS 
(phosphate buffered saline) and FBS (foetal bovine serum) 
were bought from Lonza (Verviers, Belgium). HPLC grade 
water, methanol and trifluoroacetic acid were obtained 
from Merck (Darmstadt, Germany). CO2 (99.995% purity) 
was supplied by Air Liquide (Lisbon, Portugal).
2.2 Plant material
Plant flowering aerial parts were collected at Serra dos 
Candeeiros, Portugal, and identified by Prof. Ana Isabel 
Correia, from the Herbarium of Jardim Botânico da 
Universidade de Lisboa, where a voucher specimen (LISU 
233279) was deposited.
2.3 Extracts preparation
2.3.1 Supercritical fluid extract
The volatile oil from the aerial parts of S. sclareoides 
was obtained by SFE, using 79.05 g of plant material. 
SFE apparatus was described in detail in previous work 
[11-13], and the operational conditions of pressure, 
temperature, and mean particle size of plant material, CO2 
flow rate, and amount of CO2 consumed were as follows: 
90 bar/40 °C/0.6 mm/1.1 kg h−1/4.6 kg, respectively. 
In order to obtain a pure volatile oil free of waxes, a 
fractional separation was carried out at 80 bar and -8 °C 
(first separator), and 20 bar and -15 °C (second separator). 
The amount of volatile oil collected in the second separator 
corresponds to the combination of eight fractions collected 
at t = 9.95 min, t = 29.85 min, t = 58.28 min, t = 98.01 min, 
t = 147.18 min, t = 208.00 min, t = 237.82 min and t = 252.83 
min. Extraction procedure was stopped when no more oil 
was obtained. 
2.3.2 Aqueous extract 
To prepare the infusion, boiling water (100 mL) was 
poured over dried plant (2.5 g) staying in infusion for 
30 min. Then, it was filtered on Whatman® Grade 1 filter 
paper and cooled at room temperature. For HPLC-DAD 
analysis, the infusion (5 mL) was filtered through a 0.45 
µm membrane filter (VWR) and immediately analyzed. 
The remaining infusion was lyophilized in a Heto Power 
Dry 3000 apparatus, giving the dried extract (60.24 mg), 
which was kept at 4 °C for further assays. Extract 
concentrations ranging from 0.0 to 2.0 mg/mL were 
prepared for bioactivity assays.
2.4 Phytochemical analysis
2.4.1 SFE extract
SFE volatile oil was analyzed by gas chromatography 
(GC), for component quantification, and by gas 
chromatography coupled to mass spectrometry (GC-MS) 
for component identification, as detailed in Mota et al. 
(2013) [14]. The identity of the components was assigned 
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by comparison of their retention indices, relative to C9-
C16   n-alkane indices and GC-MS spectra from a lab-made 
library (Plant Biotechnology Center, Faculty of Sciences, 
Lisbon University), constructed based on the analyses of 
reference oils, laboratory-synthesized components and 
commercial available standards [15].
2.4.2 Aqueous extract
HPLC-DAD and LC-MS/MS techniques were applied to 
the identification of infusion constituents, as previously 
described [16]. For HPLC-DAD analysis, S. sclareoides 
infusion (25 µL, 1mg/mL), was injected with an auto 
injector, and elution performed with a gradient composed 
of solution A (0.05% trifluoroacetic acid), and solution B 
(methanol) as following: 0 min, 80% A, 20% B; 20 min, 
20% A, 80% B; 25 min, 20% A, 80% B. Regarding LC–MS 
and LC–MSn, the sample was analyzed by using a linear 
gradient composed of solution A (1.0% formic acid), and 
solution B (methanol) as following: 0 min, 80% A, 20% B; 
20 min, 20% A, 80% B; 25 min, 20% A, 80% B. The mass 
spectrometer was operated in both positive and negative 
ion modes in the range m/z 120–1000, and the parameters 
were adjusted in order to optimize the signal-to-noise 
ratios (S/N) for the ions of interest [16]. 
2.5 Cytotoxicity studies with Caco-2 cells
Caco-2 cells (ATCC#HTB37), a human colorectal epithelial 
adenocarcinoma cell line, were cultured in DMEM 
supplemented with 10% FBS, 100 U/mL penicillin, 
100 µg/mL streptomycin, and 2 mM L-glutamine, at 37 °C, 
in an atmosphere with 5% CO2 [16]. The culture medium 
was changed every 48 to 72 h, and the cells were passaged 
before reaching confluence. Cytotoxicity studies were 
performed in 96-well plates, exposing the cells for 24 h 
to several concentrations (0.1 to 2.0 mg/mL) of the plant 
extracts in culture medium, and using the MTT viability 
test [17]. 
2.6 Anti-inflammatory activity
To study the in vitro anti-inflammatory activity, the 
lyophilized infusion was dissolved in Tris-buffer, pH 8, 
in concentrations ranging from 0.1 to 2.0 mg/mL. COX-1 
activity was performed as described in  previous work [18]. 
2.7 Acetylcholinesterase inhibition
Anti-acetylcholinesterase activity of the infusion was 
measured according the methodology previously reported 
[16], using adaptations of the method described by 
Ingkaninan et al. (2003) [19]. 
2.8 Antioxidant activity
The ability of the extract to inhibit the bleaching of the 
β-carotene-linoleic acid emulsion was determined using 
the method described by Khadri et al. (2010) [20] with 
a slight modification. In brief, β-carotene dissolved in 
chloroform (0.5 mg/mL), linoleic acid (25 µL) and Tween 
40 (200 mg) were added and transferred into a round-
bottom flask. When the chloroform was removed under 
vacuum, distilled water (50 mL) saturated with oxygen for 
2 h was added to the flask with vigorous stirring. Then, 2.5 
mL aliquots of this emulsion were transferred to a series 
of tubes containing the dissolved extract (100 µL) of each 
concentration and were further shaken. Absorbance of 
each sample was recorded at 470 nm immediately after 
sample preparation (t = 0 min). After that, the samples 
were placed in the dark for 18 h, at room temperature, 
together with two blanks, one containing the antioxidant 
BHT (butylated hydroxytoluene) as a positive control, 
and the other with the same volume of water instead of 
the extract. With the later tube a complete oxidation is 
obtained with the initial yellow color vanishing, while 
in the test tube with BHT, the yellow color is maintained 
during the incubation period. Tests were carried out 
in triplicate and the absorbance of each sample after 
incubation time was measured [18, 20]. Radical scavenging 
activity was evaluated by the DPPH method, as previously 
described [21].
2.9 In vitro digestions
In vitro digestions by the gastric and pancreatic juices 
were performed according the methodology described in 
[16], which was adapted from Yamamoto and co-workers 
(1999) [22]. 
2.10 Statistical analysis
All the bioassays were carried out in triplicate. The software 
used for data analysis was Microsoft ® Excel 2010 and the 
results were expressed as means ± standard deviation. 
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Additional analysis of variance (ANOVA) was performed 
with P = 0.05 and P = 0.01.
3 Results and Discussion 
3.1 Phytochemical analysis
3.1.1 SFE extract
The extraction yield of the volatile oil isolated by SFE 
from the dried flowering aerial parts of S. sclareoides was 
0.4% (g/g dry weight), which is in the same range as those 
reported for the hydrodistilled essential oils obtained 
from some other species of the genus Salvia [23-25], but 
lower than that of S. officinalis [26]. Regarding SFE, the 
yields reported in the literature for Salvia species are more 
variable and depend on the pressure and temperature 
conditions used for the extractions, and are higher for 
higher pressures [27-28]. At pressures above 90/100 
bar, other compounds may contaminate the volatile oil 
inducing the increase of the extraction yield [12]. Therefore, 
a pressure/temperature set of 90 bar/40 °C was selected in 
this work to guarantee that the chemical composition of 
the volatile oil was free of heavier compounds, namely the 
waxes present in plants.
The chemical composition of the volatile oil obtained 
by SFE from S. sclareoides was analyzed by GC-MS. 
As can be seen in Table 1, it was dominated by trans-β-
caryophyllene oxide, hexadecanoic acid, phytol acetate 
2, linoleic acid ethyl ester and hexadecanoic acid methyl 
ester. On the other hand, monoterpene hydrocarbons 
were present in trace amounts and oxygen containing 
monoterpenes were absent. 
The chemical variability among different species of 
Salvia is well known.  These results contrast with those 
described for other Salvia species submitted to SFE, such 
as S. lavandulifolia Vahl. [29], and S. officinalis L. [30-31], 
which were richer in monoterpene hydrocarbons and the 
main compounds were oxygen containing monoterpenes 
[1,8-cineole, (E)-ocimenone and camphor]. Moreover, 
hydrodistilled essential oils of several species of Salvia are 
mainly composed by monoterpene hydrocarbons (α- and 
β-pinene, limonene) or oxygen containing monoterpenes 
(1,8-cineole, camphor, α-thujone, α-terpinenyl 
acetate, linalool), depending on the species, and less 
commonly, sesquiterpenes are the major compounds 
(β-caryophyllene, caryophyllene oxide) [23-26]. On the 
other hand, the hydrodistilled essential oils of some less 
studied Salvia species contains fatty acids and their esters 
as well as diterpenoids in considerable amounts, such 
as, S. hierosolymitana (21% of fatty acids and 4.8% of 
phytol) [32], S. sclarea (12.77% of phytol) [33], S. splendens 
Scarlet Sage Red (10.99% of fatty acids and 41.46% of 
phytol) [34], and S. dorisiana (3.99% of fatty acids and 
10.81% of phytol) [34].  S. ceratophylla (29.0% of fatty 
acids and 14% of phytol) [35], S. miltiorrhiza (28.8% of 
fatty acids and aliphatic esters and 8.9% of phytol) [36], S. 
glutinosa (13.7% of phytol) [37], and S. reflexa (28% of fatty 
acids and 3% of phytol isomer) [37]. In addition, SFE of 
S. desoleana obtained at 90 bar and 50 °C was rich in the 
diterpenoid sclareol (74.6%), a compound also found in 
the hydrodistilled oil (5%) [38].  
Apart from the current study on the apolar fraction of 
S. sclareoides, only one study assessing the composition 
of its essential oil obtained by hydrodistillation has been 
published. As shown by Sepahvand et al. (2014) [39], the 
essential oil of S. sclareoides obtained by hydrodistillation 
was a complex mixture mainly composed by linalool 
(27.6%), trans-caryophyllene (16.6%), β-trans-ocimene 
(11.8%), germacrene-D (10%), bicyclogermacrene (3.3%), 
caryophyllene oxide (2.9%), linalyl acetate (2.7%), 1-octanol 
(2.0%), spathulenol (1.6%) and cis-ocimene (1.4%). Lower 
amounts of β-pinene, β-elemene, α-humulene, phytol 
and α-farnesene were also found, among other minor 
compounds. Comparing this composition with that 
obtained through using SFE, eight compounds were in 
common, and in both cases the presence of high amounts 
of sesquiterpenes was verified, conversely to the amount 
of monoterpenes.
The evolution of the volatile oil composition with 
the extraction time was also evaluated in this study 
and, as it can be seen in Table 1, changes were observed. 
Sesquiterpene hydrocarbons were only extracted in 
the first hour of extraction, while oxygen-containing 
sesquiterpenes were present in the fractions collected 
until 147.18 min (2.45 h). On the other hand, fatty acids 
and their derivatives as well as the diterpenoid phytol 
acetate 2 were extracted since the beginning of the 
extraction but corresponded to 98% of the volatile oil at 
the end of the extraction. Similar behavior was observed 
by other authors [29, 30] who described that monoterpene 
hydrocarbons and oxygen containing monoterpenes were 
mainly extracted at the beginning, with the percentage 
of lighter components decreasing with the extraction 
time. Conversely, higher-molecular-weight compounds, 
such as sesquiterpene hydrocarbons and oxygenated 
sesquiterpenes showed a continuous percentage increase 
at increasing extraction times. The authors explained this 
behavior by considering that lighter compounds have 
shorter internal diffusion times than heavier ones and are, 
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Table 1: Composition of the volatiles extracted by supercritical fluid extraction (SFE) from the dried flowering aerial parts of Salvia 
sclareoides.
Components      RI          SFE§
1 2 3 4 5 6 7 8
Benzaldehyde 927 t t t t t t t t
α-Pinene 930 t t t t t t t t
1-Octen-3-ol 961 t t t t t t t t
β-Pinene 963 t t t t t t t t
Benzene acetaldehyde 1002 t t t t t t t t
Limonene 1009 t t t t t t t t
n-Nonanal 1073 0.5 0.3 t t t t t t
cis-Theaspirane 1286 t t t t t t t t
trans-Theaspirane 1300 t t t t t t t t
n-Tridecane 1300 t t t t t t t t
Bicycloelemene 1544 t t t t t t t t
δ-Elemene 1332 t t t t t t t t
β-Elemene 1388 t t t t t t t t
trans-β-Caryophyllene 1414 2.7 1.5 t t t t t t
Guaia-6,9-diene* 1447 5.2 2.9 t t t t t t
α-Humulene 1447 0.5 0.3 t t t t t t
trans-β-Farnesene 1455 0.5 t t t t t t t
β-Ionone 1456 0.4 t t t t t t t
Bicyclogermacrene 1487 3.1 2.8 0.6 t t t t t
α-trans-trans-Farnesene 1500 t t t t t t t t
Elemol 1530 4.5 0.3 t t t t t t
trans-Nerolidol 1549 0.4 t t t t t t t
Spathulenol 1551 t 1.0 t t t t t t
trans-β-Caryophyllene oxide 1561 9.4 5.5 1.5 3.1 0.7 t t t
Globulol 1566 2.2 3.0 0.8 0.6 t t t t
α-Bisabolol 1656 t t t t t t t t
α-trans-Bergamotol 1669 t t t t t t t t
Hexadecanoic acid (= palmitic 
acid)
1908 14.6 12.6 17.1 21.3 32.1 35.5 20.9 27.6
Phytol acetate 2 2047 15.4 27.0 40.8 28.9 18.1 14.5 19.2 15.1
Linoleic acid ethyl ester 2137 15.0 11.0 14.0 19.5 19.0 14.3 19.6 18.3
Hexadecanoic acid methyl ester 2137 15.1 14.4 20.5 20.5 27.5 30.9 39.1 37.0
% of Identification 89.5 82.6 95.3 93.9 97.4 95.2 98.8 98.0
Grouped Components
Monoterpene hydrocarbons t t t t t t t t
Sesquiterpene hydrocarbons 12.0 7.5 0.6 t t t t t
Oxygen-containing 
sesquiterpenes
16.5 9.8 2.3 3.7 0.7 t t t
C13 components 0.4 t t t t t t t
Others 60.6 65.3 92.4 90.2 96.7 95.2 98.8 98.0
RI = Retention index relative to C9-C22 n-alkanes on the DB-1 column; t = trace (<0.05%), * based on mass spectra only.
 § Eight fractions of volatile oil collected in the second separator at different times.
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thus, more readily available. To the best of our knowledge 
this is the first report on the chemical composition of 
the SFE-volatile oil, free of waxes, from S. sclareoides, 
contributing to the extent of knowledge on the chemical 
composition of the genus Salvia.
3.1.2 Aqueous extract
The infusion of S. sclareoides was analyzed by HPLC-DAD 
(Fig.1) and its main components were tentatively identified 
by LC-MS/MS (Table 2). 
The identification of each peak (Fig. 1 and Table 2) 
was based on the fragmentation patterns in MS2 and MS3 
experiments, and comparison with literature and Mass 
Bank data base [40].
Rosmarinic acid was identified as the major component 
of the infusion, and its fragmentation pattern is in full 
agreement with the previously reported data [9, 41]. In 
addition, this compound has also been appointed as the 
major constituent of other Salvia species [1, 42].  Luteolin 
derivatives, like luteolin diglucuronide [1], and luteolin-7-
O-(6´´O-acetylglucoside) [9], as well as sagerinic acid [43], 
were also detected in minor amounts in the S. sclareoides 
infusion. 
3.2 Toxicity evaluation in Caco-2 cells
Extracts´ cytotoxicity was evaluated by the MTT 
(methylthiazolyldiphenyl-tetrazolium bromide) method. 
It is based on the cellular reduction of tetrazolium salts 
to dyed formazan-based products by mitochondrial 
dehydrogenases, providing information on cell 
metabolism [44]. Despite some limitations of this method, 
when applied to plant extracts [45-46], it is a rapid 
and inexpensive assay for a preliminary cell viability 
evaluation. Although infusions of S. sclareoides are 
taken traditionally by people, the cytotoxicity of its SFE 
extracts remains unknown. The extracts were analyzed 
concerning their toxicity towards Caco-2 cell line, which is 
an accepted model for intestinal cells [47]. The cells were 
incubated 24 h with different concentrations (0.1-2 mg/mL) 
of the extracts and, even with the highest concentration (2 
mg/mL), the inhibitions were below 50% for all extracts 
(Fig. 2) and therefore IC50 values could not be reached. 
None of the extracts tested can be considered toxic 
as generally IC50 values above 0.1 mg/mL are referred 
as non-toxic [48]. However, with 2 mg/mL, the three 
first fractions of the SFE extract presented toxicities 
significantly different from 0% (the control, untreated 
cells), respectively, SFE1 (13.5 ± 2.4%), SFE2 (12.4 ± 1.1%) 
and SFE3 (19.7 ± 3.2%), in opposition to the infusion that 
showed no significant toxicity (0.39 ± 0.55%) even with 
Figure 1: HPLC-DAD chromatogram of Salvia sclareoides infusion: 
(1) unknown, (2) luteolin diglucuronide, (3) sagerinic acid, (4) 
rosmarinic acid, (5) luteolin-7-O-(6´´- O-acetylglucoside).
Table 2: Putative identification of compounds present in Salvia 
sclareoides infusion by LC-MS.
Peak RT 
(min)
[M-H]- Main product 
ions (m/z)
Compound 
1 3.5 223 178, 118, 113, 
89
Unknown
2 8.6 637 381, 351, 285 Luteolin diglucuronide
3 9.1 719 539, 521, 359, 
341
Sagerinic acid
4 11.1 359 197, 179, 161 Rosmarinic acid 
(Massbank score 0.732, 
Massbank IDPR100686)
5 12.5 489 285, 241, 199, 
175, 151
Luteolin acetylglucoside 
(Massbank score for 
the aglycone 0.941, 
Massbank ID BML00144)
Figure 2: Toxicity of the infusion (Inf.) and of the first three fractions 
(SFE1-3) of the supercritical fluid extract from Salvia sclareoides for 
Caco-2 cells, presented as % of decrease in cell viability.
 * Values statistically different from the control (P < 0.05).
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2 mg/mL (Fig. 2). Therefore, caution must be taken when 
ingesting the SFE extracts, as the toxic values may be 
more easily reached and cause gastrointestinal problems, 
when compared to the infusion. These results also show 
that the traditional preparation of S. sclareoides extracts 
as an infusion may be the safest way of ingesting the 
plant extract, and so, we pursued our research work on 
bioactivities of the lyophilized infusion.
3.3 Anti-inflammatory activity 
Non-steroid anti-inflammatory drugs have important 
therapeutic interest in the treatment of inflammatory 
diseases, since they are widely used for the treatment 
of pain, inflammation and fever. It is assumed that 
the main mechanism of action of these drugs consists 
in the inhibition of the cyclooxygenase enzymes: the 
constitutive cyclooxygenase-1 (COX-1) and the inducible 
cyclooxygenase-2 (COX-2) isoenzymes that catalyze the 
conversion of arachidonic acid into prostaglandins 
(PGs), whose contribution to the process of inflammation 
is well known [49]. Recently, COX-1 isoenzyme has 
been receiving increased attention, also because of its 
involvement in many health problems [50]. In brain, COX-
1, predominantly localized in microglia, is an important 
player in neuroinflammation [51], being involved in 
several neurodegenerative diseases including Alzheimer’s 
disease, Parkinson’s disease, and traumatic brain injury, 
among others [50]. In order to investigate the potential 
of COX-1 as therapeutic target, selective COX-1 inhibitors 
have been developed [52]. These findings encouraged 
us to evaluate the ability of S. sclareoides infusion to 
inhibit COX-1 and we found that it inhibited the enzyme 
(IC50 = 271.0 ± 4.0 µg/mL) in a dose dependent manner, 
evidencing a moderate inhibitory activity. 
3.4 Acetylcholinesterase inhibition 
The infusion of this plant is traditionally used for 
the prevention of cognitive detrimental status. Once 
acetylcholinesterase is an enzyme involved in the depletion 
of the neurotransmitter acetylcholine, its inhibition may 
be a target to reverse cognitive disorders. S. sclareoides 
infusion significantly inhibited the enzyme AChE (IC50 = 
487.7 ± 14.8 µg/mL). Rosmarinic acid, the major phenolic 
component of the infusion, has shown to be an inhibitor 
of the acetylcholinesterase activity [53], and so we can 
assume that this phenolic compound has an important 
role on the anticholinesterase effect of the herbal tea. To 
corroborate this assumption, our previous studies on NMR 
spectroscopy binding experiments of S. sclareoides crude 
extracts in the presence of AChE, determined rosmarinic 
acid as the only explicit binder to this enzyme [9].
3.5 Antioxidant capacity
Antioxidant activity was evaluated through two different 
assays: β- Carotene/linoleic acid bleaching test and DPPH 
free radical-scavenging activity. In the first, a model 
system made of β-carotene and linoleic acid undergoes 
a rapid discoloration in the absence of an antioxidant. 
The free linoleic acid radical formed upon the abstraction 
of a hydrogen atom from one of its methylene groups 
attacked the β-carotene molecules, which lost the double 
bonds and therefore its characteristic orange color [54]. 
Regarding the DPPH test, it measures the capacity of 
the extracts to scavenge the stable radical 2,2-diphenyl-
1-picrylhydrazyl formed in solution. If the extracts have 
the capacity to scavenge the DPPH free radical, the initial 
blue/purple solution will change to a yellow color, due to 
the formation of diphenylpicrylhydrazine [55]. 
When evaluated by the β-carotene assay, S. 
sclareoides infusion presented an IC50 of 30.0 ± 5.9 µg/mL, 
indicating that the extract has a significant antioxidant 
activity, when compared to the synthetic antioxidant BHT 
(IC50 = 4.5 ± 0.8 µg/mL). Regarding the DPPH assay, the 
obtained IC50 (10.4 ± 0.4 µg/mL) evidences a good radical 
scavenging activity. When compared to other extracts 
from the same plant species, also studied by our group 
[8], the infusion evidences a better antioxidant activity 
in both assays. Regarding other Salvia species, although 
their chemical variability and the different method of 
extract preparation influence bioactivities, our results 
add further support to the well documented antioxidant 
and anticholinesterase properties of extracts from this 
genus [56-60], evidencing their potential for therapeutic 
exploitation.
3.6 In vitro digestion by gastric and pancreatic 
juices and remaining bioactivities
In traditional medicine, S. sclareoides is taken orally, 
meaning that infusion components are subjected to 
gastrointestinal conditions. An in vitro simulation of such 
conditions allows to predict absorption and distribution 
of its components assuring that they can exert their 
bioactivities. The in vitro digestions were made with 
artificial gastric and pancreatic juices, mimicking the 
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digestion in the gastrointestinal tract, and the infusion was 
analyzed, in the beginning and after digestion, by HPLC. 
Moreover, the antioxidant and anti-acetylcholinesterase 
activities were also evaluated. 
The composition of the plant extract was not 
significantly altered neither in gastric nor in pancreatic 
digestion, which is in accordance with previous studies 
showing the stability of rosmarinic acid, the main 
component, under in vitro digestive conditions [61-
63]. Concerning the extract bioactivities, no significant 
alterations were observed in the antioxidant activity 
after the digestion with gastric juice (99.3 ± 9.4%), which 
agrees with the HPLC analysis that showed no remarkable 
changes in the extract composition. After pancreatic 
digestion, the final antioxidant activity (100.5 ± 8.3%) 
remained similar to the initial one, indicating that the 
main antioxidant components of the infusion persisted 
intact. It is known that AChE inhibitors stimulate 
gastrointestinal motility [61], enhancing the potential 
purgative properties of S. sclareoides infusion. Although 
a slight decrease in the acetylcholinesterase inhibition 
was observed after pancreatic digestion (82.4 ± 8.1%), 
the inhibitory capacity of the extract increased to 105.3 ± 
10.9% after gastric digestion. This demonstrates that the 
plant infusion is not only active, but also that its bioactive 
components may reach the intestine.
Dietary intervention studies in several mammalian 
species, using phenolic rich extracts, have indicated 
an ability to improve memory, by protecting vulnerable 
neurons, or by stimulating neuronal regeneration [64]. 
In addition, the anti-inflammatory properties of phenolic 
compounds [65], contribute to their neuroprotective effects 
through their capacity to reduce oxidative imbalance. 
Based on these findings, S. sclareoides can be regarded 
as an important source of multitarget bioactive molecules 
with potential to the prevention of neurodegenerative and 
age-related chronic diseases.
4 Conclusions
SFE can be regarded as an adequate methodology 
to obtain volatiles from S. sclareoides in good yields. 
Although, at high concentrations, the SFE extract has 
denoted some cytotoxicity to Caco-2 cells, when compared 
to the infusion, its potential to be used for agricultural 
and pharmaceutical formulations with antimicrobial 
properties needs to be explored. Regarding the non-toxic 
aqueous extract, a simulated in vitro digestion, evidenced 
no remarkable alterations in the composition or in the 
bioactivities, suggesting that the infusion can pass 
through the gastrointestinal tract, keeping its composition 
and biological properties. The present work reinforces the 
results of our previous research on S. sclareoides extracts 
and adds further support to the use of the infusion 
as a source of multitarget bioactive molecules with 
potential application on the prevention and treatment of 
neurodegenerative diseases.
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